| review article | Q7318358 |
| scholarly article | Q13442814 |
| systematic review | Q1504425 |
| meta-analysis | Q815382 |
| P50 | author | Shaul Lev-Ran | Q88400282 |
| Tomer Avni | Q114778580 | ||
| Adi Lador | Q114778587 | ||
| Leonard Leibovici | Q28037183 | ||
| Mical Paul | Q28037206 | ||
| P2093 | author name string | Alon Grossman | |
| P2860 | cites work | Terlipressin in the treatment of late phase catecholamine-resistant septic shock | Q84118688 |
| A comparison of epinephrine and norepinephrine in critically ill patients | Q46463165 | ||
| Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study | Q46691567 | ||
| Current epidemiology of septic shock: the CUB-Réa Network. | Q53924344 | ||
| The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. | Q54191284 | ||
| Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? | Q54238540 | ||
| American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference | Q55879451 | ||
| Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial | Q57778873 | ||
| American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis | Q68141412 | ||
| Regional blood flow and oxygen transport in septic shock | Q72920953 | ||
| Low-dose vasopressin in the treatment of vasodilatory septic shock | Q73099859 | ||
| Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study | Q73182846 | ||
| [Use of vasopressin to correct hemodynamic disorders in patients with abdominal sepsis] | Q80467545 | ||
| Comparison of Dopamine and Norepinephrine in the Treatment of Shock | Q22250880 | ||
| Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine | Q22306067 | ||
| Vasopressors for hypotensive shock | Q24234415 | ||
| Estimating the mean and variance from the median, range, and the size of a sample | Q24801782 | ||
| Early goal-directed therapy in the treatment of severe sepsis and septic shock | Q27860596 | ||
| Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care | Q27860820 | ||
| A randomized trial of protocol-based care for early septic shock | Q29617931 | ||
| Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock | Q30711418 | ||
| Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock | Q31056350 | ||
| Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials | Q34173190 | ||
| Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*. | Q34228515 | ||
| Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock | Q34314380 | ||
| Has the mortality of septic shock changed with time | Q34756226 | ||
| Vasopressin versus norepinephrine infusion in patients with septic shock. | Q34756330 | ||
| Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update | Q35877109 | ||
| Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock | Q35908131 | ||
| Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. | Q37105993 | ||
| Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study | Q37360357 | ||
| Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. | Q39889699 | ||
| Comparison of phenylephrine and norepinephrine in the management of dopamine-resistant septic shock | Q41189097 | ||
| Comparative study of dopamine and norepinephrine in the management of septic shock | Q41828695 | ||
| Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Emphasis on right ventricular performance | Q42138175 | ||
| Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? | Q42601060 | ||
| Efficacy and safety of dopamine versus norepinephrine in the management of septic shock | Q43256319 | ||
| Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial | Q43412778 | ||
| Circulating vasopressin levels in septic shock. | Q43465970 | ||
| Beneficial effects of short-term vasopressin infusion during severe septic shock | Q43901842 | ||
| Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock. | Q44052241 | ||
| Effects of dopamine and norepinephrine on systemic and hepatosplanchnic hemodynamics, oxygen exchange, and energy balance in vasoplegic septic patients | Q44901850 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vasoconstrictor agents | Q3359124 |
| systematic review | Q1504425 | ||
| septic shock | Q1765564 | ||
| meta-analysis | Q815382 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e0129305 | |
| P577 | publication date | 2015-08-03 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis | |
| P478 | volume | 10 |
| Q89579726 | Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock |
| Q92843795 | Central venous pressure value can assist in adjusting norepinephrine dosage after the initial resuscitation of septic shock |
| Q64126295 | Challenges in the management of septic shock: a narrative review |
| Q91741502 | Combination era, using combined vasopressors showed benefits in treating septic shock patients: a network meta-analysis of randomized controlled trials |
| Q64055906 | Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials |
| Q64126327 | Current use of vasopressors in septic shock |
| Q90265411 | Dopamine in critically ill patients with cardiac dysfunction: A systematic review with meta-analysis and trial sequential analysis |
| Q39348712 | Dopaminergic Regulation of Innate Immunity: a Review. |
| Q33790629 | Guanabenz Prevents d-Galactosamine/Lipopolysaccharide-Induced Liver Damage and Mortality |
| Q92619915 | Health economic evaluations of sepsis interventions in critically ill adult patients: a systematic review |
| Q57170719 | Hotspot Analysis of Sepsis Literature |
| Q89532710 | Methylene blue administration in patients with refractory distributive shock - a retrospective study |
| Q30235974 | New Consensus Definitions for Sepsis and Septic Shock: Implications for Treatment Strategies and Drug Development? |
| Q38983589 | Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review. |
| Q39615420 | Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis |
| Q37344946 | Potentially Preventable Deaths by Intensive Care Medicine in Mongolian Hospitals |
| Q34047325 | Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure |
| Q65002000 | Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial. |
| Q64067786 | Sepsis: The evolution in definition, pathophysiology, and management |
| Q38433744 | Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. |
| Q89586654 | Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children |
| Q88637018 | Symmetrical peripheral gangrene in sepsis after treatment with inotropes |
| Q64897538 | Terlipressin as a first choice in septic shock—not yet. |
| Q87791624 | The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016) |
| Q50052469 | The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). |
| Q64072823 | Timing of administration of epinephrine predicts the responsiveness to epinephrine in norepinephrine-refractory septic shock: a retrospective study |
| Q39428917 | Update of Sepsis in the Intensive Care Unit. |
| Q90660286 | Use of vasopressin in the treatment of refractory septic shock |
| Q28068818 | Vasoactive agents for the treatment of sepsis |
| Q64910237 | Vasopressin in Pediatric Critical Care. |
| Q24186138 | Vasopressors for hypotensive shock |
Search more.